Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Parikh

Showing results (1061-1070 of 1,087) with videos related to

Pageof 109
Sort By:
JAMA Internal Medicine|October 20, 2020
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19Shruti Gupta, Wei Wang, Salim S Hayek, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 24, 2012
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodologyPaul M Palevsky, Bruce A Molitoris, Mark D Okusa, et al.
JAMA|November 16, 2014
Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trialAmit X Garg, Andrea Kurz, Daniel I Sessler, et al.
JCO Precision Oncology|September 2, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic CancerRishi Surana, Micaela Morgado, Ashwin Somasundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2024
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal CancerHarshabad Singh, Pranshu Sahgal, Kevin Kapner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2021
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal CancerAparna R Parikh, Emily E Van Seventer, Giulia Siravegna, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 12, 2018
Patterns of proton therapy use in pediatric cancer management in 2016: An international surveyNeige Journy, Daniel J Indelicato, Diana R Withrow, et al.
Nature Medicine|January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trialJun Tian, Jonathan H Chen, Sherry X Chao, et al.
Nature Medicine|November 21, 2019
Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancersAparna R Parikh, Ignaty Leshchiner, Liudmila Elagina, et al.
Medrxiv : the Preprint Server for Health Sciences|March 13, 2026
Shared multicellular injury programs of acute and chronic kidney disease enable mechanistic patient stratificationRobin Fallegger, Sergio A Gomez-Ochoa, Charlotte Boys, et al.
Pageof 109

Showing results (1061-1070 of 1,087) with videos related to

Sort By:
Pageof 109
JAMA Internal Medicine|October 20, 2020
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19Shruti Gupta, Wei Wang, Salim S Hayek, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 24, 2012
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodologyPaul M Palevsky, Bruce A Molitoris, Mark D Okusa, et al.
JAMA|November 16, 2014
Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trialAmit X Garg, Andrea Kurz, Daniel I Sessler, et al.
JCO Precision Oncology|September 2, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic CancerRishi Surana, Micaela Morgado, Ashwin Somasundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2024
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal CancerHarshabad Singh, Pranshu Sahgal, Kevin Kapner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2021
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal CancerAparna R Parikh, Emily E Van Seventer, Giulia Siravegna, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 12, 2018
Patterns of proton therapy use in pediatric cancer management in 2016: An international surveyNeige Journy, Daniel J Indelicato, Diana R Withrow, et al.
Nature Medicine|January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trialJun Tian, Jonathan H Chen, Sherry X Chao, et al.
Nature Medicine|November 21, 2019
Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancersAparna R Parikh, Ignaty Leshchiner, Liudmila Elagina, et al.
Medrxiv : the Preprint Server for Health Sciences|March 13, 2026
Shared multicellular injury programs of acute and chronic kidney disease enable mechanistic patient stratificationRobin Fallegger, Sergio A Gomez-Ochoa, Charlotte Boys, et al.
Pageof 109